z-logo
Premium
Long‐term outcome in epilepsy with grand mal on awakening: Forty years of follow‐up
Author(s) -
Holtkamp Martin,
Kowski Alexander B.,
Merkle Hannah,
Janz Dieter
Publication year - 2014
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.24103
Subject(s) - epilepsy , antiepileptic drug , odds ratio , medicine , confidence interval , grand mal , pediatrics , retrospective cohort study , psychiatry
Epilepsy with grand mal on awakening (EGMA) is a well‐defined subtype of idiopathic generalized epilepsy. Patients with follow‐up of at least 20 years were assessed retrospectively regarding 5‐year terminal seizure remission. Forty‐two patients were included (mean age = 60 ± 13 years). After follow‐up of 40 ± 13 years, 26 patients (62%) were in remission, 5 without antiepileptic drugs. Age at investigation (odds ratio = 0.939, 95% confidence interval = 0.887–0.994, p  = 0.029) independently predicted lacking remission. Nineteen patients (45.2%) had withdrawn from antiepileptic drugs at least once; 12 of those (63.2%) had seizure relapse. EGMA has a favorable long‐term prognosis. With increasing age and treatment duration, antiepileptic drug withdrawal may be justified. Ann Neurol 2014;75:298–302

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom